Skip to main content
    I

    ICU Medical Inc (ICUI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $181.87
    +2.60 (+1.45%)

    Market Cap: $4.48B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    ICU Medical Inc (ICUI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    ICU Medical reported revenue of $2.23B for the fiscal year ended Dec 31, 2025, down 6.3% from the year before. That year, net income was $732.00K with a net margin of 0.0%, operating cash flow was $179.85M and free cash flow was $91.80M. The quarter ended Sep 30, 2026 had revenue of $560.44M and net income of $26.85M.

    Revenue and Margins

    The operating margin was 1.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $379.37M, a compound annual rate of 21.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.23B-6.3%36.8%1.9%0.0%
    Dec 2024$2.38B+5.4%34.6%1.8%-4.9%
    Dec 2023$2.26B-0.9%32.8%1.0%-1.3%
    Dec 2022$2.28B+73.2%30.6%-1.9%-3.3%
    Dec 2021$1.32B+3.6%37.3%9.4%7.8%
    Dec 2020$1.27B+0.4%36.3%7.7%6.8%
    Dec 2019$1.27B-9.6%37.3%8.5%8.0%
    Dec 2018$1.40B+8.3%40.7%2.1%2.1%
    Dec 2017$1.29B+240.7%33.0%-1.0%5.3%
    Dec 2016$379.37MN/A53.1%21.9%16.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$2.23B$2.38B$2.26B$2.28B$1.32B$1.27B$1.27B$1.40B$1.29B$379.37M
    Cost of revenue$1.41B$1.56B$1.52B$1.58B$824.82M$809.51M$794.34M$830.01M$866.52M$177.97M
    Gross profit$822.04M$824.78M$739.87M$697.76M$491.49M$461.50M$471.86M$570.03M$426.10M$201.40M
    Research and development$87.50M$88.61M$85.34M$92.98M$47.50M$42.95M$48.61M$52.87M$51.25M$12.96M
    Operating income$42.83M$42.96M$22.82M-$42.90M$123.25M$98.16M$107.36M$29.76M-$13.29M$82.94M
    Net income$732.00K-$117.69M-$29.66M-$74.29M$103.14M$86.87M$101.03M$28.79M$68.64M$63.08M
    EBITDA$311.56M$277.40M$274.42M$244.26M$221.39M$190.94M$192.59M$98.45M$120.05M$105.69M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$560.44M$551.68M$530.23M$540.70M$536.99M$548.87M$604.70M$629.80M$589.13M$596.46M$566.65M$587.86M
    Gross profit$234.75M$235.05M$206.23M$202.99M$200.88M$208.06M$210.11M$227.26M$204.85M$207.43M$185.24M$171.59M
    Operating income$52.32M$39.13M$13.58M$5.63M$13.72M$10.59M$12.89M$37.69M$8.24M$7.69M-$10.65M-$12.18M
    Net income$26.85M$19.09M$30.13M-$15.73M-$3.40M$35.34M-$15.48M-$23.83M-$32.98M-$21.41M-$39.47M-$17.15M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $1.28B exceeded cash and equivalents by $976.70M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$4.05B$4.20B$4.38B$4.52B$1.88B$1.76B$1.69B$1.59B$1.50B$704.69M
    Current assets$1.19B$1.44B$1.22B$1.24B$1.03B$920.78M$882.20M$927.04M$864.66M$569.10M
    Cash and equivalents$307.96M$308.57M$254.22M$208.78M$552.83M$396.10M$268.67M$344.78M$290.07M$445.08M
    Total liabilities$1.93B$2.24B$2.26B$2.43B$264.71M$261.43M$315.14M$321.74M$298.70M$44.53M
    Short-term debt$18.75M$51.00M$55.88M$29.69M$0$26.30M$0$6.15M$9.06MN/A
    Long-term debt$1.27B$1.53B$1.58B$1.62BN/AN/AN/A$20.59M$55.33M$1.11M
    Shareholder equity$2.12B$1.97B$2.12B$2.09B$1.62B$1.50B$1.38B$1.26B$1.20B$660.15M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$3.94B$3.97B$4.01B$4.05B$4.10B$4.11B$4.18B$4.20B$4.31B$4.29B$4.29B$4.38B
    Total liabilities$1.75B$1.82B$1.90B$1.93B$1.98B$1.99B$2.20B$2.24B$2.26B$2.25B$2.22B$2.26B
    Cash and equivalents$301.78M$298.30M$288.33M$307.96M$299.73M$300.02M$289.70M$308.57M$312.51M$302.65M$251.42M$254.22M
    Shareholder equity$2.19B$2.15B$2.11B$2.12B$2.13B$2.12B$1.99B$1.97B$2.05B$2.04B$2.07B$2.12B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 51.0% of operating cash flow. Share repurchases came to 9.6% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$179.85M$204.03M$166.20M-$62.13M$267.54M$222.75M$101.92M$160.22M$154.42M$89.94M
    Capital expenditures$88.04M$79.37M$83.89M$90.31M$68.54M$92.00M$97.31M$92.72M$74.48M$23.36M
    Free cash flow$91.80M$124.66M$82.31M-$152.44M$199.00M$130.75M$4.61M$67.50M$79.94M$66.58M
    Dividends paidN/AN/A$9.35M$10.88M$1.04M$317.00KN/AN/A$0$0
    Share repurchases$8.77M$11.99M$9.35M$10.88M$8.34M$12.88M$18.64M$6.25M$4.06M$17.23M
    Investing cash flow$122.23M-$88.96M-$87.95M-$1.91B-$90.69M-$98.14M-$166.89M-$103.37M-$266.87M$16.28M
    Financing cash flow-$311.52M-$55.80M-$35.98M$1.64B-$16.87M-$40.00K-$10.91M$8.02M-$44.35M$2.47M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$99.59M$80.15M$38.91M$60.60M$56.71M$11.21M$51.33M$40.19M$36.10M$81.95M$45.79M$91.27M
    Capital expenditures$16.19M$18.51M$11.30M$24.65M$29.08M$19.70M$14.62M$24.08M$19.91M$19.47M$15.91M$29.94M
    Free cash flow$83.40M$61.64M$27.61M$35.95M$27.63M-$8.48M$36.71M$16.11M$16.19M$62.49M$29.88M$61.33M
    Last 12 quarters

    Frequently Asked Questions About ICUI

    What is ICU Medical's annual revenue?

    ICU Medical reported revenue of $2.23B for the fiscal year ended Dec 31, 2025.

    How fast is ICU Medical's revenue growing?

    Revenue was down 6.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.7%.

    Is ICU Medical profitable?

    Yes. ICU Medical reported net income of $732.00K for the fiscal year ended Dec 31, 2025, with a net margin of 0.0%.

    How much free cash flow does ICUI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $179.85M minus capital expenditures of $88.04M produced free cash flow of $91.80M.

    How much debt does ICU Medical have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.27B, short-term debt of $18.75M and cash and equivalents of $307.96M.